Turn Therapeutics

(NASDAQ) TTRX

Current Price$3.80

Market Cap$112.89M

Since IPO (2025)-46%

5 YearN/A

1 YearN/A

1 Month+8%

Turn Therapeutics Financials at a Glance

Market Cap

$112.89M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.87

EPS (TTM)

$0.00

P/E Ratio

-28.62

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$3.80

Volume

Open

$3.87

Price

$3.80

Volume

Open

$3.87

Previous Close

$3.79

Daily Range

$3.78 - $3.90

52-Week Range

$2.57 - $26.50

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$3.80

Volume

Open

$3.87

Previous Close

$3.79

Daily Range

$3.78 - $3.90

52-Week Range

$2.57 - $26.50

TTRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Turn Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Bradley Burnam

Website

turntherapeutics.com

Headquarters

Westlake Village, CA 91362, US

TTRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-95%

Return on Assets

-26%

Earnings Yield

-3.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$112.89M

Shares Outstanding

29.79M

Volume

Avg. Volume

21.70K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.86M

EBITDA

$5.81M

Operating Cash Flow

$2.56M

Capital Expenditure

$152.99K

Free Cash Flow

$2.72M

Cash & ST Invst.

$5.08M

Total Debt

$80.38K

Turn Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$112.89M

N/A

Market Cap/Employee

$56.45M

N/A

Employees

N/A

Net Income

$1.24M

N/A

EBITDA

$1.37M

N/A

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$5.00M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$34.08K

N/A

Short Term Debt

$46.30K

N/A

Return on Assets

-26.26%

N/A

Return on Invested Capital

-95.13%

N/A

Free Cash Flow

N/A

Operating Cash Flow

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SEERSeer, Inc.

SEERSeer, Inc.$1.84-1.34%

ANIXAnixa Biosciences, Inc.

ANIXAnixa Biosciences, Inc.$3.01+0.33%

AGENAgenus Inc.

AGENAgenus Inc.$3.30-13.61%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.21-0.41%

IKTInhibikase Therapeutics, Inc.

IKTInhibikase Therapeutics, Inc.$2.08+0.97%

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.39+0.42%

TVGNTevogen Bio Holdings Inc.

TVGNTevogen Bio Holdings Inc.$7.40-1.07%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.90+0.08%

NVTSNavitas Semiconductor

NVTSNavitas Semiconductor$23.50+0.29%

IONQIonQ

IONQIonQ$57.00+0.16%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.09-0.01%

DGXXDigi Power X

DGXXDigi Power X$7.53+0.14%

QCOMQualcomm

QCOMQualcomm$237.14+0.08%

MARAMara Holdings

MARAMara Holdings$13.68+0.06%

Questions About TTRX

What is the current price of Turn Therapeutics?

Turn Therapeutics is trading at $3.80 per share.

What is the 52-week range for Turn Therapeutics?

Over the past 52 weeks, Turn Therapeutics has traded between $2.57 and $26.50.

How much debt does Turn Therapeutics have?

As of the most recent reporting period, Turn Therapeutics reported total debt of $80,376.

How much cash does Turn Therapeutics have on hand?

Turn Therapeutics reported $5.08M in cash and cash equivalents in its most recent financial results.

What is Turn Therapeutics’s dividend yield?

Turn Therapeutics does not currently have a dividend yield.

Turn Therapeutics

Turn Therapeutics Financials at a Glance

TTRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Turn Therapeutics

TTRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Turn Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TTRX

What is the current price of Turn Therapeutics?

What is the 52-week range for Turn Therapeutics?

How much debt does Turn Therapeutics have?

How much cash does Turn Therapeutics have on hand?

What is Turn Therapeutics’s dividend yield?

Premium Investing Services